Chloe E. Barr

606 total citations
20 papers, 403 citations indexed

About

Chloe E. Barr is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Chloe E. Barr has authored 20 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Obstetrics and Gynecology, 16 papers in Reproductive Medicine and 5 papers in Surgery. Recurrent topics in Chloe E. Barr's work include Endometrial and Cervical Cancer Treatments (15 papers), Ovarian cancer diagnosis and treatment (14 papers) and Endometriosis Research and Treatment (6 papers). Chloe E. Barr is often cited by papers focused on Endometrial and Cervical Cancer Treatments (15 papers), Ovarian cancer diagnosis and treatment (14 papers) and Endometriosis Research and Treatment (6 papers). Chloe E. Barr collaborates with scholars based in United Kingdom and Italy. Chloe E. Barr's co-authors include Emma J. Crosbie, Kelechi Njoku, Roya Behrouzi, Y. Louise Wan, Eleanor Jones, Helena O’Flynn, Davide Chiasserini, Anthony D. Whetton, Luke Mounce and Garth Funston and has published in prestigious journals such as PLoS ONE, Carcinogenesis and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

Chloe E. Barr

19 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chloe E. Barr United Kingdom 12 194 163 95 88 83 20 403
M.M. Boisen United States 13 200 1.0× 169 1.0× 70 0.7× 46 0.5× 101 1.2× 45 401
E. Vaucel France 6 104 0.5× 218 1.3× 64 0.7× 99 1.1× 139 1.7× 12 421
Aeran Seol South Korea 9 149 0.8× 168 1.0× 47 0.5× 60 0.7× 70 0.8× 31 351
Domenico Ferraioli France 10 80 0.4× 87 0.5× 135 1.4× 43 0.5× 117 1.4× 27 314
Daisuke Shintani Japan 10 77 0.4× 129 0.8× 82 0.9× 76 0.9× 84 1.0× 34 293
Liudmila Velikokhatnaya United States 6 83 0.4× 166 1.0× 95 1.0× 76 0.9× 113 1.4× 7 359
Ümran Küçükgöz Güleç Türkiye 12 207 1.1× 89 0.5× 84 0.9× 31 0.4× 37 0.4× 46 390
Gianbattista Spatti Italy 12 169 0.9× 295 1.8× 99 1.0× 59 0.7× 62 0.7× 19 489
Teresa C. Longoria United States 9 88 0.5× 90 0.6× 168 1.8× 25 0.3× 48 0.6× 14 308

Countries citing papers authored by Chloe E. Barr

Since Specialization
Citations

This map shows the geographic impact of Chloe E. Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe E. Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe E. Barr more than expected).

Fields of papers citing papers by Chloe E. Barr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloe E. Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe E. Barr. The network helps show where Chloe E. Barr may publish in the future.

Co-authorship network of co-authors of Chloe E. Barr

This figure shows the co-authorship network connecting the top 25 collaborators of Chloe E. Barr. A scholar is included among the top collaborators of Chloe E. Barr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloe E. Barr. Chloe E. Barr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evans, Colin E., et al.. (2024). Measuring HE4 alongside CA125 for ovarian cancer diagnosis: A pilot clinical study. BJOG An International Journal of Obstetrics & Gynaecology. 131(12). 1725–1726.
2.
Barr, Chloe E., et al.. (2023). Serum HE4 predicts progestin treatment response in endometrial cancer and atypical hyperplasia: A prognostic study. BJOG An International Journal of Obstetrics & Gynaecology. 130(8). 941–948. 2 indexed citations
3.
Barr, Chloe E., Kelechi Njoku, G Owens, & Emma J. Crosbie. (2023). Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women. Cancers. 15(4). 1256–1256. 11 indexed citations
4.
Njoku, Kelechi, Chloe E. Barr, & Emma J. Crosbie. (2022). Current and Emerging Prognostic Biomarkers in Endometrial Cancer. Frontiers in Oncology. 12. 890908–890908. 48 indexed citations
5.
Njoku, Kelechi, et al.. (2022). Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer. Cancers. 14(14). 3306–3306. 13 indexed citations
7.
Barr, Chloe E., Kelechi Njoku, Eleanor Jones, & Emma J. Crosbie. (2022). Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features. Diagnostics. 12(11). 2834–2834. 11 indexed citations
8.
Owens, G, et al.. (2022). Urinary biomarkers for the detection of ovarian cancer: a systematic review. Carcinogenesis. 43(4). 311–320. 4 indexed citations
11.
Barr, Chloe E., et al.. (2021). Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer. Practical Laboratory Medicine. 26. e00235–e00235. 10 indexed citations
12.
Njoku, Kelechi, et al.. (2021). Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis. Gynecologic Oncology. 164(1). 146–153. 26 indexed citations
13.
Behrouzi, Roya, Chloe E. Barr, & Emma J. Crosbie. (2021). HE4 as a Biomarker for Endometrial Cancer. Cancers. 13(19). 4764–4764. 53 indexed citations
14.
Barr, Chloe E., Kelechi Njoku, Neil Ryan, et al.. (2021). Does Clinical and Biochemical Thyroid Dysfunction Impact on Endometrial Cancer Survival Outcomes? A Prospective Database Study. Cancers. 13(21). 5444–5444. 8 indexed citations
15.
Barr, Chloe E., Neil Ryan, Y. Louise Wan, et al.. (2021). Weight Loss During Intrauterine Progestin Treatment for Obesity-associated Atypical Hyperplasia and Early-Stage Cancer of The Endometrium. Cancer Prevention Research. 14(11). 1041–1050. 30 indexed citations
16.
Njoku, Kelechi, Davide Chiasserini, Eleanor Jones, et al.. (2020). Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer. Frontiers in Oncology. 10. 559016–559016. 56 indexed citations
17.
Njoku, Kelechi, et al.. (2020). Impact of socio‐economic deprivation on endometrial cancer survival in the North West of England: a prospective database analysis. BJOG An International Journal of Obstetrics & Gynaecology. 128(7). 1215–1224. 20 indexed citations
18.
Barr, Chloe E. & Emma J. Crosbie. (2020). The Mirena coil is a suitable treatment of early‐stage endometrial cancer in obese women. BJOG An International Journal of Obstetrics & Gynaecology. 127(8). 1001–1001. 10 indexed citations
20.
Barr, Chloe E., et al.. (2014). Cerebral oedema following robotic surgery: a rare complication. Archives of Gynecology and Obstetrics. 290(5). 1041–1044. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026